Literature DB >> 19299440

Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.

T Chitnis1, B Glanz, S Jaffin, B Healy.   

Abstract

BACKGROUND: The prevalence of pediatric-onset multiple sclerosis (MS) in the United States is unknown.
OBJECTIVE: In a large cohort of MS patients, we sought to identify the proportion with first symptom-onset below the age of 18 years, and to compare their demographic and disease characteristics to a typical adult-onset MS population.
METHODS: Patients seen at the Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Boston, Massachusetts, with clinical histories and characteristics of first symptoms recorded in an electronic database, were included in this study.
RESULTS: We found that 3.06% of patients with a recorded MS history experienced a first attack under the age of 18 years of age compared to 30.83% of patients who experienced first symptoms between the ages of 25-35 years. Gender proportions were similar in both groups, with the exception of a lower female preponderance in pre-pubertal-onset patients. There was a higher proportion of non-Caucasians in the younger cohort. Localization of first symptoms was similar in the two groups.
CONCLUSION: About 3% of MS patients experience their first symptom prior to the age of 18 years. Standardized follow-up is required after a first demyelinating attack in childhood, which may lead to earlier diagnosis and treatment of pediatric-onset MS.

Entities:  

Mesh:

Year:  2009        PMID: 19299440     DOI: 10.1177/1352458508101933

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  56 in total

Review 1.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

2.  Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.

Authors:  Amy T Waldman; Girish Hiremath; Robert A Avery; Amy Conger; Stacy L Pineles; Michael J Loguidice; Lauren S Talman; Kristin M Galetta; Michael J Shumski; James Wilson; E'tona Ford; Amy M Lavery; Darrel Conger; Benjamin M Greenberg; Jonas H Ellenberg; Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Journal:  Mult Scler Relat Disord       Date:  2013-05-01       Impact factor: 4.339

3.  Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.

Authors:  L E Charvet; E H O'Donnell; A L Belman; T Chitnis; J M Ness; J Parrish; M Patterson; M Rodriguez; E Waubant; B Weinstock-Guttman; L B Krupp
Journal:  Mult Scler       Date:  2014-03-31       Impact factor: 6.312

4.  Ethical challenges in paediatric clinical trials in multiple sclerosis.

Authors:  Silvia N Tenembaum
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

5.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

Review 6.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

7.  Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study.

Authors:  M S Vishwas; T Chitnis; R Pienaar; B C Healy; P E Grant
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

8.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 9.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

10.  Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.

Authors:  Adeline Vanderver; Heather Hussey; Johanna L Schmidt; William Pastor; Heather J Hoffman
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.